CN108404191A - graphene oxide/lidocaine sponge dressing and preparation method thereof - Google Patents

graphene oxide/lidocaine sponge dressing and preparation method thereof Download PDF

Info

Publication number
CN108404191A
CN108404191A CN201810372838.1A CN201810372838A CN108404191A CN 108404191 A CN108404191 A CN 108404191A CN 201810372838 A CN201810372838 A CN 201810372838A CN 108404191 A CN108404191 A CN 108404191A
Authority
CN
China
Prior art keywords
graphene oxide
lidocaine
sponge dressing
added
polyvinyl alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810372838.1A
Other languages
Chinese (zh)
Other versions
CN108404191B (en
Inventor
万绵水
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201810372838.1A priority Critical patent/CN108404191B/en
Publication of CN108404191A publication Critical patent/CN108404191A/en
Application granted granted Critical
Publication of CN108404191B publication Critical patent/CN108404191B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/24Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/425Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402Anaestetics, analgesics, e.g. lidocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602Type of release, e.g. controlled, sustained, slow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/12Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The present invention relates to a kind of graphene oxide/lidocaine sponge dressings and preparation method thereof.Sponge dressing includes following raw material components:20~500g polyvinyl alcohol, 1~20mL graphene oxides/lidocaine inclusion compound, 0.01~15g foaming agents, 10~400mL catalyst and 10~400mL crosslinking agents;Wherein, a concentration of 5~20mg/mL of graphene oxide/lidocaine inclusion compound.Compared with prior art, medical sponge dressing of the present invention combines the excellent properties such as graphene oxide, Li Kaduoyin and polyvinyl alcohol, have many advantages, such as that quick imbibition, a large amount of imbibitions, lock moisture big, antibacterial, analgesia, flexibility and elasticity are high, patient can be treated rapidly to be wound skin, mitigate the great pain that the surface of a wound is brought.In addition, medical sponge dressing simple production process of the present invention, cheap, easily realize industrialized production, be with a wide range of applications.

Description

Graphene oxide/lidocaine sponge dressing and preparation method thereof
Technical field
The present invention relates to biomedical material technologies, and in particular to a kind of graphene oxide/lidocaine sponge is deposited Material and preparation method thereof.
Background technology
In recent years, with the fast development of transportation, petrochemical industry, construction industry etc., burn is in work and daily life Incidence, disability rate and the death rate in work all increase year by year.According to statistics, China is every year because in the death toll of unexpected injury, Burn arranges the 2nd, is only second to traffic accident injury.Wherein, China's burn Annual occurence rate about 2%, and about 5% burn patient needs Hospitalization, for burn patient there are about the different degrees of deformity of 10% generation, this is all heavy to sufferers themselves, family and society in hospital The burden of weight, is relationship happy family life, the significant problem of social stability.Therefore, it should treat, make as early as possible after skin is by wound Tissue and functional rehabilitation, especially Burn Emergency patient are often patient just injured or that the injury time is short, and mood is eager, Doctor's processing surface of a wound at once is wished, to mitigate the great pain that the surface of a wound is brought.
For above-mentioned present situation, tradition mostly uses greatly gauze and is used as medical dressing, gauze have protect the surface of a wound, derive from a wealth of sources, Make the advantages that simple, cheap;But disadvantage is equally prominent:Surface of a wound wetting is cannot keep, histocyte epithelialization, wound are interfered Face healing delay;Dressing fiber is easy to fall off, causes foreign body reaction, influences to heal;Wound granulation tissue easily grows into the mesh of dressing In, when dressing, easily causes pain;Haemostatic effect is not good enough, and pathogen easily penetrates;The tissue of easy damaged new life when dressing;Dressing work Work amount is big.
Based on this, there is an urgent need to invent a kind of quick imbibition, analgesic while having the dressing with slow release long-acting at present.
Invention content
For the defects in the prior art, the present invention is intended to provide a kind of graphene oxide/lidocaine sponge dressing and Preparation method.It is excellent that medical sponge dressing provided by the invention combines graphene oxide, Li Kaduoyin and polyvinyl alcohol etc. It is anisotropic can, have many advantages, such as big quick imbibition, a large amount of imbibitions, lock moisture, antibacterial, analgesia, flexibility and elastic high, can be rapid Treatment patient is wound skin, mitigates the great pain that the surface of a wound is brought.In addition, medical sponge dressing simple production process of the present invention, It is cheap, it easily realizes industrialized production, is with a wide range of applications.
To achieve the above object, technical solution provided by the invention is:
In a first aspect, the present invention provides a kind of sponge dressing, the raw material components of sponge dressing include graphene oxide/benefit Cacaine inclusion compound, and a concentration of 5~20mg/mL of graphene oxide/lidocaine inclusion compound.
Preferably, the raw material components of sponge dressing further include polyvinyl alcohol, foaming agent, catalyst and crosslinking agent.
Preferably, the ratio of polyvinyl alcohol, graphene oxide/lidocaine inclusion compound, foaming agent, catalyst and crosslinking agent It is followed successively by (20~500) g:(1~20) mL:(0.01~15) g:(10~400) mL:(10~400) mL.
Preferably, foaming agent selects OP-10 or TX-100, and catalyst selects sulfuric acid or hydrochloric acid, crosslinking agent select formaldehyde or Geniposide.
Second aspect, the present invention provide a kind of preparation method of sponge dressing, include the following steps:S101:By polyethylene Alcohol is added in deionized water, and heating stirring is cooled to room temperature to being completely dissolved, obtains polyvinyl alcohol water solution later;S102: Graphene oxide/lidocaine inclusion compound is added in polyvinyl alcohol water solution, stirs evenly, obtains graphene oxide/benefit card Because of alkene polyvinyl alcohol blending liquid;S103:Foaming agent is added in graphene oxide/lidocaine alkene polyvinyl alcohol blending liquid, fills Divide and stirs evenly;S104:Catalyst is added in the solution that S103 is obtained, preset time is stirred under preset temperature;S105: The reaction was continued after addition crosslinking agent in the product that S104 is obtained, and by reaction product baking molding, is compressed and washed later to neutrality, obtains sea Continuous dressing.
Preferably, further include step after S105:Sponge dressing is cut, later with clamping plate by sponge pressure for 1~ 2mm, the vacuum compression at 30~50 DEG C.
Preferably, in S101, the addition of deionized water is 5~10 times of polyvinyl alcohol quality, and preferably 7 times;S104 In, preset temperature is 25~30 DEG C, and preset time is 3~5min;In S105, the time that the reaction was continued is 20~25min, baking Molding temperature is 50~70 DEG C.
Preferably, the preparation method of graphene oxide/lidocaine inclusion compound includes the following steps:S201:Stone will be aoxidized Black alkene is added in deionized water and is ultrasonically treated, and obtains graphene oxide dispersion;S202:Lidocaine hydrochloride is used into second Alcohol is dissolved, and graphene oxide dispersion is added later and is ultrasonically treated;S203:The solution that S202 is obtained is continued to stir It mixes, adjusts pH value later to 6 hereinafter, obtaining graphene oxide/lidocaine inclusion compound.
Preferably, the preparation method of graphene oxide includes the following steps:S301:It uses graphite for raw material, mixing is added Potassium permanganate is added in acid later, in being reacted under confined conditions;Wherein, mixed acid selects sulfuric acid and phosphoric acid;S302:It will The reaction product that S301 is obtained is cooled to room temperature, and hydrogen peroxide is added under the conditions of ice-water bath later, until glassy yellow is presented in solution After carry out centrifugal treating;S303:Solid phase after centrifugal treating is washed, until supernatant liquor pH value reaches neutral, later It collects solid product and carries out frozen dried, obtain graphene oxide.
Technical solution provided by the invention has following advantageous effect:
(1) applicant has found by many experiments:Medical sponge dressing provided by the invention combines graphene oxide, profit The excellent properties such as Ka Duoyin and polyvinyl alcohol have quick imbibition, a large amount of imbibitions, lock big moisture, antibacterial, analgesia, flexibility And elasticity it is high the advantages that, patient can be treated rapidly and be wound skin, the great pain that the surface of a wound is brought is mitigated.In addition, the present invention cures It is cheap with sponge dressing simple production process, it easily realizes industrialized production, is with a wide range of applications.
(2) as a kind of superfine medical sponge dressing, raw material selection and proportioning are scientific and reasonable for dressing of the present invention;Its In, the active oxygen-containing functional group of graphene surface determines it with active charge affinity, and huge specific surface area can be with Many drugs are loaded, can achieve the effect that release for a long time slow.Lidocaine or its salt use most extensive as current local anaesthesia Antalgesic, can be used for the surgical anesthesias such as surface anesthesia, infiltration anesthesia, peridural anesthesia, burn etc. the surface of a wound application in profit More cacaines significantly reduce the feeling of pain of patient.
(3) this nano material of graphene oxide is added in the present invention in PVA sponges, improves the imbibition of PVA sponge materials Amount, graphene oxide have the two-dimensional sheet material of cellular single layer structure, large specific surface area, excellent physical and chemical performance and good life Object compatibility.In addition, the addition of stannic oxide/graphene nano material can provide a payload space for lidocaine, in turn Control the permanent efficient release of lidocaine.
The additional aspect and advantage of the present invention will be set forth in part in the description, and will partly become from the following description Obviously, or practice through the invention is recognized.
Description of the drawings
Fig. 1 is the flow diagram of medical dressing preparation method in the embodiment of the present invention.
Specific implementation mode
Following will be combined with the drawings in the embodiments of the present invention, and technical solution in the embodiment of the present invention carries out clear, complete Site preparation describes.The following examples are only intended to illustrate the technical solution of the present invention more clearly, therefore is intended only as example, without It can be limited the scope of the invention with this.
Experimental method in following embodiments is unless otherwise specified conventional method.Examination as used in the following examples Material is tested, is to be commercially available from conventional reagent shop unless otherwise specified.Quantitative test in following embodiment, is all provided with Three repeated experiments are set, data are the average value or mean+SD of three repeated experiments.
The present invention provides a kind of sponge dressing, and raw material components include 20~500g polyvinyl alcohol, 1~20mL graphite oxides Alkene/lidocaine inclusion compound, 0.01~15g foaming agents, 10~400mL catalyst and 10~400mL crosslinking agents, and graphite oxide A concentration of 5~20mg/mL of alkene/lidocaine inclusion compound.
In addition, for the sponge dressing of the present invention, applicant specially provides preparation method, as shown in Figure 1, including following Step:
S101:Polyvinyl alcohol being added in the deionized water of 5~10 times of amounts, gradually stirring is warming up to 90 DEG C and is completely dissolved, It is cooled to room temperature later, obtains polyvinyl alcohol water solution.
S102:Graphene oxide/lidocaine inclusion compound is added in polyvinyl alcohol water solution, stirs evenly, obtains oxygen Graphite alkene/lidocaine alkene polyvinyl alcohol blending liquid.
S103:Foaming agent is added in graphene oxide/lidocaine alkene polyvinyl alcohol blending liquid, stirs.
S104:Catalyst is added in the solution that S103 is obtained, 3~5min is stirred at 25~30 DEG C.
S105:The reaction was continued 20~25min after crosslinking agent is added in the product that S104 is obtained, by reaction product in 50~ Baking molding at 70 DEG C compresses and washes later to neutrality, obtains sponge dressing.
S106:Sponge dressing is cut, is later 1~2mm, the vacuum pressure at 30~50 DEG C by sponge pressure with clamping plate Contracting.
Wherein, the preparation method of graphene oxide/lidocaine inclusion compound includes the following steps:S201:By graphite oxide Alkene is added in deionized water and is ultrasonically treated, and obtains graphene oxide dispersion;S202:Lidocaine hydrochloride is used into ethyl alcohol It is dissolved, graphene oxide dispersion is added later and is ultrasonically treated;S203:The solution that S202 is obtained is continued to stir It mixes, adjusts pH value later to 6 hereinafter, obtaining graphene oxide/lidocaine inclusion compound.
The preparation method of graphene oxide includes the following steps:S301:It uses graphite for raw material, mixed acid is added, later Potassium permanganate is added, in being reacted under confined conditions;Wherein, mixed acid selects sulfuric acid and phosphoric acid;S302:S301 is obtained Reaction product is cooled to room temperature, and hydrogen peroxide is added under the conditions of ice-water bath later, until solution is centrifuged after glassy yellow is presented Processing;S303:Solid phase after centrifugal treating is washed, until supernatant liquor pH value reaches neutral, collects solid phase production later Object simultaneously carries out frozen dried, obtains graphene oxide.
The present invention is further explained in the light of specific embodiments.
Embodiment one
The present embodiment provides a kind of preparation methods of graphene oxide, include the following steps:Graphite is prepared into oxidation stone Black alkene, the sulfuric acid and phosphoric acid mixed acid that 3g graphite powders are put into 500mL single-necked flasks, 300mL is added later, is slowly added to Gao Meng Sour potassium is sealed with sealed membrane at 50 DEG C, is stirred to react 15h, uses 400mL ice-water baths after being cooled to room temperature, and in ice-water bath condition The lower hydrogen peroxide that mass percentage concentration is added and is 30%, by being added soon and slowly until glassy yellow, low-speed centrifugal is presented in solution;It will be from Heart product moves on in beaker, and salt acid centrifuging is added and washes 2 times, ethyl alcohol centrifuge washing is added 2 times, and secondary deionized water washs 6 times directly Reach neutral to supernatant liquor pH value, is graphene oxide by product progress frozen dried.
Embodiment two
Based on the graphene oxide that embodiment one is prepared, the present embodiment provides a kind of graphene oxide/lidocaines The preparation method of inclusion compound, includes the following steps:
It takes 50mg graphene oxides that 25mL deionized waters are added and is ultrasonically treated 30min, graphene oxide solution is shifted To 100mL round-bottomed flasks, graphene oxide dispersion is obtained.Lidocaine hydrochloride 200mg is weighed, is dissolved in 3mL absolute ethyl alcohols, Then it is 400W, frequency 40kHz that 7mL graphene oxide dispersions, ultrasonic 30min, and ultrasonic power, which is added,;It stirs overnight later It mixes, adjusts pH value to 6 hereinafter, graphene oxide/lidocaine inclusion compound of a concentration of 20mg/mL is made;It is subsequently placed in 4 DEG C of ice It is spare in case.
The graphene oxide that embodiment two is prepared/lidocaine inclusion compound is used for the preparation process of sponge dressing In, specifically include following embodiment:
Embodiment three
The present embodiment provides a kind of preparation methods of sponge dressing, include the following steps:
S101:30g polyvinyl alcohol is added in 210g deionized waters, gradually stirring is warming up to 90 DEG C and is completely dissolved, then It is cooled to room temperature, obtains polyvinyl alcohol water solution.
S102:Graphene oxide/lidocaine hydrochloride inclusion of the 20mg/mL of 3mL is added in polyvinyl alcohol water solution Object stirs evenly, and obtains graphene oxide/lidocaine alkene polyvinyl alcohol blending liquid.
S103:Foaming agent is added in graphene oxide/lidocaine alkene polyvinyl alcohol blending liquid, stirs.
S104:Catalyst is added in the solution that S103 is obtained, uniform stirring 5min keeps temperature to stablize at 30 DEG C.
S105:The reaction was continued 25min after crosslinking agent is added in the product that S104 is obtained, reaction product is poured into grinding tool Box, 50 DEG C of baking moldings, compresses and washes later to neutrality, obtains sponge dressing.
S106:The sponge dressing that S105 is obtained is cut, is later 2mm by sponge pressure with clamping plate, it is true at 45 DEG C Pneumatics contracts, and obtains final product compressed sponge dressing.
Example IV
The present embodiment provides a kind of preparation methods of sponge dressing, include the following steps:
S101:80g polyvinyl alcohol is added in 560g deionized waters, gradually stirring is warming up to 90 DEG C and is completely dissolved, then It is cooled to room temperature, obtains polyvinyl alcohol water solution.
S102:Graphene oxide/lidocaine hydrochloride inclusion of the 20mg/mL of 12mL is added in polyvinyl alcohol water solution Object stirs evenly, and obtains graphene oxide/lidocaine alkene polyvinyl alcohol blending liquid.
S103:Foaming agent is added in graphene oxide/lidocaine alkene polyvinyl alcohol blending liquid, stirs.
S104:Catalyst is added in the solution that S103 is obtained, uniform stirring 5min keeps temperature to stablize at 30 DEG C.
S105:The reaction was continued 25min after crosslinking agent is added in the product that S104 is obtained, reaction product is poured into grinding tool Box, 50 DEG C of baking moldings, compresses and washes later to neutrality, obtains sponge dressing.
S106:The sponge dressing that S105 is obtained is cut, is later 2mm by sponge pressure with clamping plate, it is true at 45 DEG C Pneumatics contracts, and obtains final product compressed sponge dressing.
Embodiment five
The present embodiment provides a kind of preparation methods of sponge dressing, include the following steps:
S101:300g polyvinyl alcohol is added in 2100g deionized waters, gradually stirring is warming up to 90 DEG C and is completely dissolved, so Postcooling obtains polyvinyl alcohol water solution to room temperature.
S102:Graphene oxide/lidocaine hydrochloride inclusion of the 20mg/mL of 60mL is added in polyvinyl alcohol water solution Object stirs evenly, and obtains graphene oxide/lidocaine alkene polyvinyl alcohol blending liquid.
S103:Foaming agent is added in graphene oxide/lidocaine alkene polyvinyl alcohol blending liquid, stirs.
S104:Catalyst is added in the solution that S103 is obtained, uniform stirring 5min keeps temperature to stablize at 30 DEG C.
S105:The reaction was continued 25min after crosslinking agent is added in the product that S104 is obtained, reaction product is poured into grinding tool Box, 50 DEG C of baking moldings, compresses and washes later to neutrality, obtains sponge dressing.
S106:The sponge dressing that S105 is obtained is cut, is later 2mm by sponge pressure with clamping plate, it is true at 45 DEG C Pneumatics contracts, and obtains final product compressed sponge dressing.
It should be noted that the case where being enumerated in addition to above-described embodiment one to embodiment five, selects other preparation methods Parameter is also feasible.
Medical sponge dressing provided by the invention combines the superiority such as graphene oxide, Li Kaduoyin and polyvinyl alcohol Can, have many advantages, such as quick imbibition, a large amount of imbibitions, lock moisture big, antibacterial, analgesia, flexibility and elastic high, can treat rapidly Patient is wound skin, mitigates the great pain that the surface of a wound is brought.In addition, medical sponge dressing simple production process of the present invention, price It is cheap, it easily realizes industrialized production, is with a wide range of applications.
It should be noted that unless otherwise indicated, technical term or scientific terminology used in this application should be this hair The ordinary meaning that bright one of ordinary skill in the art are understood.Unless specifically stated otherwise, it otherwise illustrates in these embodiments Component and opposite step, numerical expression and the numerical value of step are not limit the scope of the invention.It is illustrated and described herein In all examples, unless otherwise prescribed, any occurrence should be construed as merely illustrative, not as limitation, because This, other examples of exemplary embodiment can have different values.
Finally it should be noted that:The above embodiments are only used to illustrate the technical solution of the present invention., rather than its limitations;To the greatest extent Present invention has been described in detail with reference to the aforementioned embodiments for pipe, it will be understood by those of ordinary skill in the art that:Its according to So can with technical scheme described in the above embodiments is modified, either to which part or all technical features into Row equivalent replacement;And these modifications or replacements, various embodiments of the present invention technology that it does not separate the essence of the corresponding technical solution The range of scheme should all cover in protection scope of the present invention.

Claims (9)

1. a kind of sponge dressing, it is characterised in that:
The raw material components of the sponge dressing include graphene oxide/lidocaine inclusion compound, and the graphene oxide/benefit A concentration of 5~20mg/mL of cacaine inclusion compound.
2. sponge dressing according to claim 1, it is characterised in that:
The raw material components of the sponge dressing further include polyvinyl alcohol, foaming agent, catalyst and crosslinking agent.
3. sponge dressing according to claim 2, it is characterised in that:
The polyvinyl alcohol, the graphene oxide/lidocaine inclusion compound, the foaming agent, the catalyst and the friendship The usage ratio of connection agent is followed successively by (20~500) g:(1~20) mL:(0.01~15) g:(10~400) mL:(10~400) mL.
4. sponge dressing according to claim 2 or 3, it is characterised in that:
The catalyst selects sulfuric acid or hydrochloric acid, the crosslinking agent to select formaldehyde or Geniposide.
5. the preparation method of any one of claim 2~4 sponge dressing, which is characterized in that include the following steps:
S101:Polyvinyl alcohol is added in deionized water, heating stirring is cooled to room temperature to being completely dissolved, obtains poly- second later Enol aqueous solution;
S102:Graphene oxide/lidocaine inclusion compound is added in the polyvinyl alcohol water solution, stirs evenly, obtains oxygen Graphite alkene/lidocaine alkene polyvinyl alcohol blending liquid;
S103:Foaming agent is added in the graphene oxide/lidocaine alkene polyvinyl alcohol blending liquid, stirs;
S104:Catalyst is added in the solution that the S103 is obtained, preset time is stirred under preset temperature;
S105:The reaction was continued after addition crosslinking agent in the product that the S104 is obtained, and reaction product baking molding is pressed later It is washed till neutrality, obtains sponge dressing.
6. the preparation method of sponge dressing according to claim 5, it is characterised in that:
Further include step S106 after the S105:Sponge dressing is cut, is later 1~2mm by sponge pressure with clamping plate, The vacuum compression at 30~50 DEG C.
7. the preparation method of sponge dressing according to claim 5, it is characterised in that:
In the S101, the addition of the deionized water is 5~10 times of the polyvinyl alcohol quality, and preferably 7 times;
In the S104, the preset temperature is 25~30 DEG C, and the preset time is 3~5min;
In the S105, the time that the reaction was continued is 20~25min, and the temperature of the baking molding is 50~70 DEG C.
8. the preparation method of sponge dressing according to claim 5, it is characterised in that:
The preparation method of the graphene oxide/lidocaine inclusion compound includes the following steps:
S201:It adds graphene oxide into deionized water and is ultrasonically treated, obtain graphene oxide dispersion;
S202:Lidocaine hydrochloride is dissolved using ethyl alcohol, the graphene oxide dispersion is added later and is surpassed Sonication;
S203:The obtained solution of the S202 is continued to stir, adjusts pH value later to 6 hereinafter, obtaining graphene oxide/benefit Cacaine inclusion compound.
9. the preparation method of sponge dressing according to claim 8, it is characterised in that:
The preparation method of the graphene oxide includes the following steps:
S301:It uses graphite for raw material, mixed acid is added, potassium permanganate is added later, in being reacted under confined conditions;Its In, the mixed acid selects sulfuric acid and phosphoric acid;
S302:The obtained reaction products of the S301 are cooled to room temperature, hydrogen peroxide is added under the conditions of ice-water bath later, until Solution carries out centrifugal treating after glassy yellow is presented;
S303:Solid phase after the centrifugal treating is washed, until supernatant liquor pH value reaches neutral, collects solid phase later Product simultaneously carries out frozen dried, obtains graphene oxide.
CN201810372838.1A 2018-04-24 2018-04-24 Graphene oxide/lidocaine sponge dressing and preparation method thereof Active CN108404191B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810372838.1A CN108404191B (en) 2018-04-24 2018-04-24 Graphene oxide/lidocaine sponge dressing and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810372838.1A CN108404191B (en) 2018-04-24 2018-04-24 Graphene oxide/lidocaine sponge dressing and preparation method thereof

Publications (2)

Publication Number Publication Date
CN108404191A true CN108404191A (en) 2018-08-17
CN108404191B CN108404191B (en) 2019-11-22

Family

ID=63136464

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810372838.1A Active CN108404191B (en) 2018-04-24 2018-04-24 Graphene oxide/lidocaine sponge dressing and preparation method thereof

Country Status (1)

Country Link
CN (1) CN108404191B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109045343A (en) * 2018-09-04 2018-12-21 天津信氏佳科技发展有限公司 A kind of Chinese gall absorption chip and its preparation method and application for absorbent article
CN109731129A (en) * 2018-08-31 2019-05-10 西南民族大学 A kind of bletilla compound hemostatic sponge and preparation method thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004062600A3 (en) * 2003-01-08 2004-11-04 Lectec Corp Antiviral patch
CN103787317A (en) * 2014-01-02 2014-05-14 上海应用技术学院 Preparation method of graphene oxide dispersion liquid
CN103950923A (en) * 2014-05-07 2014-07-30 山东玉皇新能源科技有限公司 New method for preparing high-quality graphene
CN105504618A (en) * 2016-01-19 2016-04-20 武汉工程大学 Polyvinyl alcohol-chitosan-graphene oxide sponge and preparation method thereof
CN107158450A (en) * 2017-05-27 2017-09-15 武汉维斯第医用科技股份有限公司 Graphene oxide modified sponge for negative-pressure sealed drainage and preparation method thereof
CN107929319A (en) * 2017-12-14 2018-04-20 吉林大学 A kind of graphene nano silver lidocaine sustained-release antibacterial gel

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004062600A3 (en) * 2003-01-08 2004-11-04 Lectec Corp Antiviral patch
CN103787317A (en) * 2014-01-02 2014-05-14 上海应用技术学院 Preparation method of graphene oxide dispersion liquid
CN103950923A (en) * 2014-05-07 2014-07-30 山东玉皇新能源科技有限公司 New method for preparing high-quality graphene
CN105504618A (en) * 2016-01-19 2016-04-20 武汉工程大学 Polyvinyl alcohol-chitosan-graphene oxide sponge and preparation method thereof
CN107158450A (en) * 2017-05-27 2017-09-15 武汉维斯第医用科技股份有限公司 Graphene oxide modified sponge for negative-pressure sealed drainage and preparation method thereof
CN107929319A (en) * 2017-12-14 2018-04-20 吉林大学 A kind of graphene nano silver lidocaine sustained-release antibacterial gel

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
申玉坤等: "功能性氧化石墨烯-β -环糊精/利多卡因包合物的制备及其质量评价", 《药物分析杂志》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109731129A (en) * 2018-08-31 2019-05-10 西南民族大学 A kind of bletilla compound hemostatic sponge and preparation method thereof
CN109045343A (en) * 2018-09-04 2018-12-21 天津信氏佳科技发展有限公司 A kind of Chinese gall absorption chip and its preparation method and application for absorbent article
CN109045343B (en) * 2018-09-04 2021-05-18 天津信氏佳科技发展有限公司 Galla chinensis absorption chip for absorption product and preparation method and application thereof

Also Published As

Publication number Publication date
CN108404191B (en) 2019-11-22

Similar Documents

Publication Publication Date Title
CN103073665B (en) High-strength and temperature-sensitive polymer-graphene oxide composite hydrogel and conductive graphene composite hydrogel as well as preparation methods thereof
CN106729927B (en) Modified bioactive glass/polyacrylamide/oxidized sodium alginate hydrogel dressing and preparation method thereof
CN108404191B (en) Graphene oxide/lidocaine sponge dressing and preparation method thereof
CN103908693B (en) A kind of bionic-type alginic acid base composite antibiotic dressing and preparation method thereof
CN112107723B (en) Medical water-based adhesive and using method thereof
CN101700409A (en) Material prepared from purely natural material and used for wounds
CN103965639A (en) Antibacterial anticoagulant high polymer material, and preparation method and application thereof
CN104874014A (en) Preparation method of medical hemostatic occlusion dressing
Ouyang et al. Rapidly degrading and mussel-inspired multifunctional carboxymethyl chitosan/montmorillonite hydrogel for wound hemostasis
CN101502667A (en) Medical chitosan transparent hydrogel wound dressing as well as preparation and application thereof
CN101381500A (en) Chitin/polyvinyl alcohol composite foam material and preparation method thereof
CN104888267A (en) Medicinal bleeding-stopping spandex fiber fabric and preparation method thereof
CN106893052A (en) A kind of preparation method of graphene oxide/polyacrylamide composite aquogel
Liu et al. A smart hydrogel patch with high transparency, adhesiveness and hemostasis for all-round treatment and glucose monitoring of diabetic foot ulcers
Shi et al. Hydrogel loading 2D montmorillonite exfoliated by anti-inflammatory Lycium barbarum L. polysaccharides for advanced wound dressing
CN104018234B (en) A kind of preparation method of the composite nano-fiber membrane for being capable of quick-acting haemostatic powder
KR102497989B1 (en) Hemostatic dressings
CN112546286A (en) Antibacterial hemostatic dressing
CN107412880B (en) Preparation method of flexible transparent artificial skin receptor
CN113616847B (en) Calamine hemostatic compound based on Y molecular sieve carrier and preparation thereof
CN110483630A (en) A kind of preparation method of modified fibroin protein freeze-dried powder
CN109646704A (en) The preparation method of medical burn antiseptic anti-adhesion type gauze bandage
CN113134112B (en) Rapid imbibition expansion type composite compression hemostatic sponge and preparation method thereof
Xiong et al. Facilely prepared thirsty granules arouse tough wet adhesion on overmoist wounds for hemostasis and tissue repair
CN109731129A (en) A kind of bletilla compound hemostatic sponge and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant